TY - JOUR
T1 - The prohibitin-binding compound fluorizoline affects multiple components of the translational machinery and inhibits protein synthesis
AU - Jin, Xin
AU - Xie, Jianling
AU - Zabolocki, Michael
AU - Wang, Xuemin
AU - Jiang, Tao
AU - Wang, Dong
AU - Désaubry, Laurent
AU - Bardy, Cedric
AU - Proud, Christopher G.
PY - 2020/7/17
Y1 - 2020/7/17
N2 - Fluorizoline (FLZ) binds to prohibitin-1 and -2 (PHB1/2), which are pleiotropic scaffold proteins known to affect signaling pathways involved in several intracellular processes. However, it is not yet clear how FLZ exerts its effect. Here, we show that exposure of three different human cancer cell lines to FLZ increases the phosphorylation of key translation factors, particularly of initiation factor 2 (eIF2) and elongation factor 2 (eEF2), modifications that inhibit their activities. FLZ also impaired signaling through mTOR complex 1, which also regulates the translational machinery, e.g. through the eIF4E-binding protein 4E-BP1. In line with these findings, FLZ potently inhibited protein synthesis. We noted that the first phase of this inhibition involves very rapid eEF2 phosphorylation, which is catalyzed by a dedicated Ca2+-dependent protein kinase, eEF2 kinase (eEF2K). We also demonstrate that FLZ induces a swift and marked rise in intracellular Ca2+ levels, likely explaining the effects on eEF2. Disruption of normal Ca2+ homeostasis can also induce endoplasmic reticulum stress, and our results suggest that induction of this stress response contributes to the increased phosphorylation of eIF2, likely because of activation of the eIF2-modifying kinase PKR-like endoplasmic reticulum kinase (PERK). We show that FLZ induces cancer cell death and that this effect involves contributions from the phosphorylation of both eEF2 and eIF2. Our findings provide important new insights into the biological effects of FLZ and thus the roles of PHBs, specifically in regulating Ca2+ levels, cellular protein synthesis, and cell survival.
AB - Fluorizoline (FLZ) binds to prohibitin-1 and -2 (PHB1/2), which are pleiotropic scaffold proteins known to affect signaling pathways involved in several intracellular processes. However, it is not yet clear how FLZ exerts its effect. Here, we show that exposure of three different human cancer cell lines to FLZ increases the phosphorylation of key translation factors, particularly of initiation factor 2 (eIF2) and elongation factor 2 (eEF2), modifications that inhibit their activities. FLZ also impaired signaling through mTOR complex 1, which also regulates the translational machinery, e.g. through the eIF4E-binding protein 4E-BP1. In line with these findings, FLZ potently inhibited protein synthesis. We noted that the first phase of this inhibition involves very rapid eEF2 phosphorylation, which is catalyzed by a dedicated Ca2+-dependent protein kinase, eEF2 kinase (eEF2K). We also demonstrate that FLZ induces a swift and marked rise in intracellular Ca2+ levels, likely explaining the effects on eEF2. Disruption of normal Ca2+ homeostasis can also induce endoplasmic reticulum stress, and our results suggest that induction of this stress response contributes to the increased phosphorylation of eIF2, likely because of activation of the eIF2-modifying kinase PKR-like endoplasmic reticulum kinase (PERK). We show that FLZ induces cancer cell death and that this effect involves contributions from the phosphorylation of both eEF2 and eIF2. Our findings provide important new insights into the biological effects of FLZ and thus the roles of PHBs, specifically in regulating Ca2+ levels, cellular protein synthesis, and cell survival.
KW - calcium
KW - cancer
KW - cell death
KW - eEF2
KW - eIF2
KW - elongation
KW - endoplasmic reticulum stress (ER stress)
KW - eukaryotic initiation factor 2 (eIF2)
KW - eukaryotic translation initiation
KW - initiation
KW - prohibitin
KW - protein synthesis
KW - translation elongation factor
UR - http://www.scopus.com/inward/record.url?scp=85088496237&partnerID=8YFLogxK
U2 - 10.1074/jbc.RA120.012979
DO - 10.1074/jbc.RA120.012979
M3 - Article
C2 - 32430400
AN - SCOPUS:85088496237
SN - 1083-351X
VL - 295
SP - 9855
EP - 9867
JO - The Journal of biological chemistry
JF - The Journal of biological chemistry
IS - 29
ER -